The Accelerating Medicines Partnership (AMP) Program was launched in February 2014 to bring together the resources and expertise of both the National Institutes of Health (NIH) and the private sector to solve pressing challenges in various diseases and disease areas. Managed by the FNIH, the AMP Program is comprised of projects operating under the broad principle of delivering pre-competitive advancements to the research and medical fields to enable broad access and use of AMP research discoveries. A critical component of each public-private partnership in the AMP Program is an agreement among partners to make data and analyses arising from the collaboration publicly accessible to benefit the broader biomedical community. Individual AMP projects frequently establish public portals to rapidly disseminate data from their research efforts, and AMP-funded publications are required to be made available publicly within specific timeframes.
Your gift to the FNIH resonates across the entire field of medicine. For decades, the FNIH, as a partner to the National Institutes of Health, has advanced biomedical research and training that has improved the development of treatments and cures.
Thanks to our generous benefactors, the FNIH has devoted more than $1.5 billion to support more than 600 research programs in over 30 countries. Consistently awarded four stars from Charity Navigator, the FNIH devotes more than 90 cents of every dollar directly to our programs.
We are a Maryland 501(c)(3) not-for-profit organization. Contributions to the FNIH are deductible for federal income tax purposes in accordance with applicable law. Certain states require written disclosures for nonprofit organizations soliciting contributions.